What the firm does, who it serves, scope boundaries, engagement formats, working languages, regulatory translation, and how engagements start. Canonical answers consolidated for inbound discovery.
We identify where an internationally headquartered business is being misread in the US market and correct it. Three stages. Diagnosis: where and why the market misinterprets your business. Signal correction: positioning, pricing, messaging, trust structure. Execution layer: ads, pages, funnels, only after alignment.
About the firm →Companies already operating whose growth depends on being understood correctly in a market that does not think like their home market. Primary: international companies entering the US. Secondary: US-based companies entering the UK, Switzerland, Luxembourg, Malta, Ireland, Dubai, Singapore, or Hong Kong. Not for early-stage guessing. Not for local-only businesses.
Operators entering the US →In the US, buyers do not explore brands. They make fast decisions on signals. How you position, how you price, how you present risk. Home-market signals that read as restraint, precision, or seriousness in Munich, Zurich, or Singapore frequently read as small, slow, or evasive to the US buyer.
Read the analysis →No search-ranking work. No backlink work. No legal services, no immigration or visa work, no entity formation, no tax structuring, no banking introductions, no fiduciary services, no regulatory licensing, no IP filing, no contract drafting. These belong with qualified specialists.
Scope of services →With an inquiry and a discovery conversation. The firm runs three engagement formats: Market Entry Sprint (six to ten weeks), Cross-Border Build (three to six months), and Group Partnership (monthly retainer, twelve-month minimum). Pricing is confirmed per engagement in discovery. Pricing is not published on the public site.
Engagements →Market Entry Sprint is a six-to-ten-week diagnostic and signal-correction engagement that delivers the architecture decisions and the first operational layer. Cross-Border Build is a three-to-six-month implementation engagement that builds the full US commercial layer on top of corrected architecture. Most engagements move Sprint first, Build second.
Engagement formats →English, German, and Russian natively. Discovery and strategy can run in any of the three. Execution deliverables for US audiences are produced in English. German and Russian execution is available for material aimed at home-market or DACH or CIS audiences.
DE-Auftritt →Yes. Fiduciary referrals are a primary inbound channel. The firm does not pay introducer commissions. Engagements introduced through fiduciaries are billed directly to the operator. The fiduciary remains in their advisory role and the firm carries the cross-border architecture work. This separation is part of why fiduciaries refer.
Fiduciaries and advisors →Yes, in the reverse direction. US companies entering the UK, Switzerland, Luxembourg, Malta, Ireland, Dubai, Singapore, or Hong Kong face symmetric misreading. The same diagnostic-and-correction framework applies in reverse: the US-default register reads as aggressive, transactional, or under-credentialed in those markets.
US to international →For federal procurement: SAM.gov entity registration, NAICS code mapping, FAR and DFARS reps and certs, GSA Schedule eligibility assessment, CMMC posture for DOD work, FedRAMP pathway for cloud products. The firm builds the commercial readability layer on top of these registrations. The registrations themselves are typically handled by qualified specialists.
Procurement glossary →For medical devices: MDR clinical evidence does not equal FDA 510(k) substantial-equivalence demonstration. For automotive: European VDA submissions do not directly substitute for AIAG PPAP and APQP at Detroit Three suppliers. For cyber: ISO 27001 is necessary but not sufficient for FedRAMP or CMMC. The firm builds the commercial frame around these technical boundaries.
MedTech bridge →Discovery and proposal: one to two weeks. Market Entry Sprint: six to ten weeks from kickoff. Cross-Border Build: three to six months from kickoff. Group Partnership: monthly cadence with twelve-month minimum. Most operators that progress from Sprint to Build do so on continuous cadence; the architecture is the same and the artefacts are reused.
Engagement cadence →Sacramento, California, with native operating coverage in English, German, and Russian. Engagements are run remotely with on-site components when warranted. City-gate landing pages exist for the corridors the firm operates: London, Zurich, Geneva, Munich, Frankfurt, Vienna, Dubai, Singapore, Hong Kong, Tel Aviv, and others.
Cities →A US marketing agency builds for US buyers from a US starting point. The firm builds for international operators whose home register, pricing posture, trust signals, and category architecture do not transfer. The diagnostic comes first, the execution comes second. A US-default agency typically starts at execution and treats positioning as input rather than output.
Brand interpretation →Cross-border US market entry glossary. Federal procurement, export control, FDA pathways, automotive supplier qualification, USMCA, IRA Section 30D.
Open the glossary →The three engagement formats: Market Entry Sprint, Cross-Border Build, Group Partnership. How they sequence and where each fits.
See the formats →The signal layer in US commercial reading. Why home-market restraint reads as small. The architecture decisions that correct the misread.
Read the analysis →